By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS








Company News
Provectus Biopharmaceuticals Inc.’ PV-10 Clinical Data On The Treatment Of Melanoma To Be Presented At European Society For Medical Oncology 2014 Congress 7/23/2014 12:08:35 PM
Provectus Biopharmaceuticals Inc. Updates Shareholders In Its Annual CEO Letter 7/8/2014 11:19:16 AM
Provectus Biopharmaceuticals Inc. To Hold Conference Call Today To Detail Outline Of Phase 3 Clinical Trial Of PV-10 In Melanoma Treatment 6/19/2014 11:35:07 AM
Provectus Biopharmaceuticals Inc. To Discuss Outline Of Phase 3 Clinical Trial Of PV-10 To Treat Melanoma On Conference Call 6/12/2014 9:38:42 AM
PV-10 Data Presented At The American Society of Clinical Oncology Annual Meeting Defines Path Forward For Provectus Biopharmaceuticals Inc. 6/3/2014 9:28:02 AM
Provectus Biopharmaceuticals Inc. To Hold Conference Call Tuesday, June 3, 2014 5/28/2014 7:11:22 AM
Provectus Biopharmaceuticals Inc. Reaffirms Its Commitment To Bringing PV-10 To Market Notwithstanding FDA Decision On Breakthrough Therapy Designation 5/27/2014 8:28:12 AM
Provectus Biopharmaceuticals Inc. Refutes Inaccuracies In Seeking Alpha Article 5/22/2014 8:22:06 AM
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker To Strategic Advisory Board 5/21/2014 6:36:51 AM
Provectus Biopharmaceuticals Inc. To Celebrate NYSE MKT Listing With Opening Bell Ceremony 5/19/2014 8:23:02 AM
12345678910...
//-->